Skip to main content

Advertisement

SpringerLink
Log in

Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis—reply to Pazianas and Abrahamsen

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pazianas M, Abrahamsen B (2014) Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis. Osteoporosis Int. DOI 10.1007/s00198-014-2788-0

  2. Tadrous M, Wong L, Mamdani MM et al (2014) Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis. Osteoporos Int 25(4):1225–1235. doi:10.1007/s00198-013-2576-2

    Article  PubMed  CAS  Google Scholar 

  3. Bafeta A, Trinquart L, Seror R, Ravaud P (2013) Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ 347:f3675

    Article  PubMed  PubMed Central  Google Scholar 

  4. Druyts E, Thorlund K, Humphreys S, Lion M, Cooper CL, Mills EJ (2013) Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection. Clin Epidemiol 5:173–183

    PubMed  PubMed Central  Google Scholar 

  5. Jansen JP, Fleurence R, Devine B et al (2011) Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health: J Int Soc Pharmacoeconomics Outcome Res 14(4):417–428

    Article  Google Scholar 

  6. Boonen S, Black DM, Colon-Emeric CS et al (2010) Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc 58(2):292–299

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kennel KA, Drake MT (2009) Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 84(7):632–637, quiz 638

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20(2):109–117

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, M5S 3M2, Canada

    M. Tadrous, M. M. Mamdani, M. D. Krahn & S. M. Cadarette

  2. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

    M. M. Mamdani & M. D. Krahn

  3. Applied Health Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada

    M. M. Mamdani

  4. Sunnybrook Research Institute, Toronto, ON, Canada

    D. N. Juurlink

  5. Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada

    M. D. Krahn

  6. Department of Community Health and Epidemiology, Queen’s University, Kingston, ON, Canada

    L. E. Lévesque

Authors
  1. M. Tadrous
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. M. Mamdani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. N. Juurlink
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. D. Krahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. E. Lévesque
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. M. Cadarette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Tadrous.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tadrous, M., Mamdani, M.M., Juurlink, D.N. et al. Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis—reply to Pazianas and Abrahamsen. Osteoporos Int 25, 2671–2672 (2014). https://doi.org/10.1007/s00198-014-2789-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-014-2789-z

Keywords

Search

Navigation